Market Tracker

07/28 4:10am ET

Immunomedics Inc (NASDAQ:IMMU)

3.71
Delayed Data
As of Jul 27
 0.00 / 0.00%
Today’s Change
3.08
Today|||52-Week Range
5.48
-22.71%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.71
Today’s open3.69
Day’s range-- - --
Volume546,046
Average volume (3 months)1,031,839
Market cap$346.8M
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-18.25%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book8.78

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+1.13+6.27%
ENTLEntellus Medical Inc-0.58-2.75%
CUTRCutera Inc-0.13-0.85%
LMNSLumenis Ltd-0.01-0.07%
Data as of 07/27/2015

Financials

Next reporting dateAugust 20, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts